ctrl K

Advertisement

Satsuma Pharmaceuticals I... (STSA)

NASDAQ: STSA · Real-Time Price · USD

1.10

0.00 (0.00%)

At close: Jun 07, 2023, 8:00 PM

Satsuma Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-70.95M	-51.17M	-48.33M	-28.88M	-7.51M	-4.95M
Interest Income	905K	157K	1.11M	1.19M	72K	30K
Pretax Income	-70.06M	-51.17M	-47.56M	-28.18M	-7.35M	-5.17M
Net Income	-69.16M	-51.26M	-47.67M	-28.52M	-7.35M	-5.17M
Selling & General & Admin	15.13M	13.53M	12.06M	4.68M	1.08M	754K
Research & Development	44.09M	37.63M	36.27M	24.2M	6.43M	4.19M
Other Expenses	11.73M	n/a	n/a	-1K	n/a	n/a
Operating Expenses	59.22M	51.17M	48.33M	28.88M	7.51M	4.95M
Interest Expense	13K	163K	350K	482K	90K	15K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	59.22M	51.17M	48.33M	28.88M	7.51M	4.95M
Income Tax Expense	-892K	92K	111K	340K	259K	-210K
Shares Outstanding (Basic)	32.02M	29.17M	17.41M	5.86M	3.94M	6.8M
Shares Outstanding (Diluted)	32.02M	29.17M	17.41M	5.86M	3.94M	6.8M
EPS (Basic)	-2.16	-1.76	-2.74	-4.86	-1.86	-0.76
EPS (Diluted)	-2.16	-1.76	-2.74	-4.86	-1.86	-0.76
EBITDA	-58.31M	-50.62M	-47.21M	-27.69M	-7.2M	-5.15M
EBIT	-70.04M	-51.01M	-47.21M	-27.69M	-7.26M	-5.16M
Depreciation & Amortization	12.63M	550K	1.11M	1.19M	57K	10K